ScaleReady provides G-Rex® bioreactors and GMP raw materials to maintain cell phenotype consistency during the scale-up of cell and gene therapies. This technology addresses the challenge of cell phenotype drift, ensuring high-quality cell production from research to clinical applications.
Funding
Funding not disclosed
Founders
Product
Problem
Cell and gene therapy manufacturing faces challenges in scaling up production while maintaining consistent cell phenotype, which can lead to variability and reduced efficacy in clinical applications. Inconsistent raw material quality and supply chain uncertainties further exacerbate these challenges, potentially causing delays and increased costs.
Solution
ScaleReady offers a comprehensive platform of bioreactors, cell processing systems, gene editing technologies, and GMP raw materials designed to streamline and standardize cell and gene therapy manufacturing. The G-Rex bioreactor technology facilitates cell expansion while preserving cell phenotype across different scales, from research to clinical production. Paired with high-quality GMP reagents and customizable supply agreements, ScaleReady ensures process consistency, reduces variability, and mitigates supply chain risks. This integrated approach aims to accelerate the translation of cell therapies from research to commercialization by addressing key bottlenecks in manufacturing scalability and reproducibility.
Target Audience
ScaleReady serves cell and gene therapy developers, manufacturers, and researchers seeking scalable, consistent, and high-quality solutions for cell expansion, gene editing, and cell processing.
Features
- G-Rex bioreactors provide a consistent cell environment, maintaining cell phenotype during scale-up.
- GMP cytokines, media, and cell activation reagents ensure maximum bioactivity and reproducibility.
- TcBuster non-viral gene delivery platform enables faster, cost-effective, and reliable gene editing.
- GatheRex cell harvesting instrument facilitates efficient cell processing with minimal volumes.
- Customizable vialing, construct design, formulation, and quality control analysis are available.
- Supply agreements and GMP reagent forecasting minimize supply chain disruptions.
- Manufacturing processes adhere to ISO 13485 standards and comply with USP Chapter <1043> and Ph. Eur. General Chapter 5.2.12 guidelines.